ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Shennon Biotechnologies has raised $12.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Shennon Biotechnologies's investors include Future Ventures, DCVC, Foundation Capital, AV8 Ventures, NextGen Venture Partners.
Shennon Biotechnologies is headquartered in San Francisco, United States.
ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.
Shennon Biotechnologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shennon Biotechnologies — Funding & Investors." VCBacked, September 14, 2026, https://www.vcbacked.co/company/shennon-biotechnologies. Accessed October 30, 2026.
VCBacked. (2026). Shennon Biotechnologies — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/shennon-biotechnologies
{{cite web |title=Shennon Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/shennon-biotechnologies |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated